GeoVax, led by CEO David Dodd, received SA from EMA for its GEO-MVA and presented at a conference in New York City on September 3, 2025.
9 reports, 2 independent
Updated Aug 18
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 9
- Developments
- 2
- Repetition
- 78%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
GeoVax, led by CEO David Dodd, received SA from EMA for its GEO-MVA and presented at a conference in New York City on September 3, 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.GeoVax received SA from EMA for GEO-MVA and presented at a conference in NYC.1 source
GeoVax announced results from Atlanta, GA, alongside EMA's favorable regulatory guidance.1 source
Keep exploring
The entities involved
-
GeoVax
biotechnology company
Nothing else this week.
-
David Dodd
Australian soccer player
Nothing else this week.
-
EMA
Japanese vocalist of the group DUSTCELL
Nothing else this week.
Coverage
Newest first; wire copies grouped- NewMediaWireGeoVax to Present at the H.C. Wainwright 27th Annual Global Investment Conference Company to Provide Key Updates on GEO-MVA, GEO-CM04S1, and Gedeptin(R) Programs ATLANTA, GA - September 3, 2025 (NEWM
- GlobeNewswirePresenting on Emerging Growth Conference 85 Day 2 on August 21; Register to live stream MIAMI, Aug. 20, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announ
- NewMediaWireGeoVax Announces Allowance of Patent Protecting Multi-Antigen COVID-19 Vaccine Constructs Expands Intellectual Property Portfolio Supporting Next-Generation COVID-19 Vaccine Candidates ATLANTA, GA -
- NewMediaWireGeoVax to Present at the Emerging Growth Conference on August 20, 2025 Company to Provide Key Updates on GEO-MVA and Its Mpox Vaccine Development Program ATLANTA, GA - August 18, 2025 (NEWMEDIAWIRE)
- NewMediaWireGeoVax Reports Second Quarter 2025 Financial Results and Provides Business Update GEO-MVA received favorable European regulatory guidance supporting streamlined development pathway GEO-CM04S1 demonst
- NewMediaWireGeoVax Highlights EMA Regulatory Milestone as Catalyst for Near-Term Revenue from GEO-MVA Mpox Vaccine Positive EMA Scientific Advice Positions GeoVax for Expedited European Approval ATLANTA, GA - Ju
- NewMediaWireGeoVax to Present at the Emerging Growth Conference on July 16, 2025 Company to Provide Key Updates on GEO-MVA, GEO-CM04S1, and Gedeptin(R) Programs ATLANTA, GA - July 14, 2025 (NEWMEDIAWIRE) - GeoVa